Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCorero Network Regulatory News (CNS)

Share Price Information for Corero Network (CNS)

Share Price is delayed by 15 minutes
Get Live Data
11.25    0.00 (0.00%)
Bid:
11.00
Ask:
11.50
Spread: 0.50 (4.545%)
Market Cap: £57.62m
CNS Live PriceLast checked at - London Stock Exchange

Intraday Corero Network Share Chart

Corero Secures Initial CORE Customer Contracts

7 Jul 2025 07:00

RNS Number : 8838P
Corero Network Security PLC
07 July 2025
 

7 July 2025

 

 

Corero Network Security plc

("Corero" or the "Company")

 

Corero Secures Initial CORE Customer Contracts

 

- $1.5 million CORE platform contract expands Corero's TierPoint relationship

- $0.3 million CORE platform agreement with Cooper Health

 

Corero (AIM: CNS) (OTCQX: DDOSF), the distributed denial of service ("DDoS") protection specialists, is pleased to announce the first two customer wins adopting CORE (Corero Observability and Resiliency Ecosystem) architecture - Corero's next-generation platform designed to unify visibility and defensive action across disparate security infrastructure.

 

First announced on 29 October 2024, the CORE platform initial capabilities include Traffic Analysis ("TA"), Zero Trust Access Control ("ZTAC") and Layer 7 DDoS protection ("L7"). These capabilities are focused on operational resilience and sit adjacent to Corero's traditional DDoS protection market product suite.

 

Expansion of TierPoint Partnership

 

Corero has agreed a $1.5 million expansion of its partnership with TierPoint, a leading provider of secure, connected data centre and cloud solutions. The agreement marks the introduction of Corero's new CORE L7 (application-layer) DDoS protection, co-developed with TierPoint and designed to defend against modern, complex threats without the bloat of traditional web application firewalls.

 

Unlike legacy Web Application Firewalls that attempt to be all things to all users, Corero's L7 protection takes a focused, operational-first approach - offering targeted defences against volumetric and protocol-specific attacks at the application layer without unnecessary complexity or latency. The new capability will be integrated into TierPoint's broader security platform, enhancing its ability to protect enterprise customers operating in hybrid and multi-cloud environments.

 

Cooper Health Agreement

 

Corero has also secured a new CORE partnership with Cooper University Health Care ("Cooper Health"), a leading academic health system based in Camden, New Jersey.

 

This three-year, $0.3 million agreement includes the deployment of Corero's new ZTAC capabilities, which will provide cybersecurity protection to Cooper Health's extensive online infrastructure, including almost 14,000 employees across three hospitals.

 

The deployment marks the first implementation of ZTAC, which has been developed to ensure that only verified users and devices access critical infrastructure by enhancing operational resilience and safeguarding remote environments by enforcing authentication at the network edge.

 

These CORE customer wins, and initial expansion outside of Corero's market-leading DDoS expertise, further demonstrates the growing need for comprehensive cybersecurity solutions in an ever-evolving threat landscape.

 

Carl Herberger, Chief Executive Officer at Corero, commented:

 

"We are delighted to have secured our first CORE deployments, reinforcing our strategy to develop complementary products alongside our DDoS portfolio, and exemplifying Corero's technical leadership in this field.

 

Our close working partnership with the TierPoint security team has helped us design a Layer-7 defence that reflects what organisations actually need today: precision, speed, and adaptability. Our collaboration has resulted in an important milestone for CORE, creating a future-ready ecosystem that we believe will bring unified observability and orchestration to DDoS defence.

 

We are also delighted to be able to announce another CORE deployment win with such a fantastic partner in Cooper Health. Healthcare environments are increasingly targeted by sophisticated threats, and network access control is a critical first line of defence. We are proud to partner with Cooper Health as it leads the way in adopting zero trust frameworks to protect infrastructure and ensure continuous availability of care-critical systems."

 

Enquiries:

 

Corero Network Security plc

Tel: +44(0)20 7390 0230

Carl Herberger, Chief Executive Officer

Chris Goulden, Chief Financial Officer

 

 

Canaccord Genuity Limited (Nominated Adviser and Joint Broker)

Tel: +44(0)20 7523 8000

Simon Bridges / Andrew Potts / Harry Rees

 

Zeus Capital (Joint Broker)

Ben Robertson / Alexandra Campbell-Harris

 

 

Tel: +44(0)20 3829 5000

Vigo Consulting (Financial PR and Investor Relations)

Tel: +44(0)20 7390 0230

Jeremy Garcia / Kendall Hill / Anna Sutton

corero@vigoconsulting.com

 

Harbor Access (Investor Relations)

Jonathan Paterson

Tel: +1 475 477 9401

 

 

About Corero Network Security

 

Corero Network Security is a leading provider of DDoS protection solutions, delivering real-time, automated detection and mitigation with deep network visibility and analytics. Corero safeguards critical infrastructure across diverse deployment models-from inline to edge to hybrid cloud-and is currently developing CORE, an observability and resiliency ecosystem to unify defensive actions across the modern threat landscape. With operational centres in Marlborough, Massachusetts, USA, and Edinburgh, UK, Corero is headquartered in London and listed on the London Stock Exchange's AIM market (ticker: CNS) and the US OTCQX Market (OTCQX: DDOSF).

 

For more information, visit www.corero.com, and follow us on LinkedIn and X.

 

About Reach announcements

 

Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAQZLFBEDLXBBZ
Date   Source Headline
14th Jul 20107:19 amPRNDisposal, fund raising and directorate change
12th Jul 20107:00 amPRNAdviser - Change of Name
19th May 20102:41 pmPRNResult of AGM
11th May 20107:00 amRNSContract Win
21st Apr 20107:00 amRNSContract Win
30th Mar 20107:00 amPRNHolding(s) in Company
26th Mar 20107:00 amPRNFinal Results
19th Mar 20107:00 amRNSContract Win
26th Jan 20107:00 amPRNTrading Statement
16th Oct 20097:00 amPRNMajor Contract Extension
15th Oct 20097:01 amPRNNOMAD Change of Name
18th Sep 20091:39 pmPRNDirector/PDMR Shareholding
17th Sep 20097:00 amPRNHalf-yearly Report
30th Jun 20094:03 pmPRNTotal Voting Rights
29th Jun 20093:27 pmPRNResult of Meeting
4th Jun 20097:00 amPRNAmendment to the CULS and Capital Reorganisation
26th Mar 20097:00 amPRNFinal Results
20th Jan 20097:00 amPRNTrading Statement
8th Aug 20087:00 amPRNHalf-yearly Report
21st May 20083:33 pmRNSResults of Meeting
19th May 20082:02 pmPRNDirectorate Change
31st Mar 200811:58 amPRNGrant of Options
25th Mar 20085:09 pmPRNDirector/PDMR Shareholding
20th Mar 20087:00 amPRNFinal Results
23rd Nov 20074:24 pmPRNDirector/PDMR Shareholding
23rd Nov 20077:00 amPRNTrading Statement and Board Changes
6th Nov 200710:52 amPRNHolding(s) in Company
6th Nov 20077:01 amRNSNew Contract for Blue Curve
27th Sep 20077:01 amRNSInterim Results
24th Sep 200710:30 amPRNChange of Registered Office
14th Aug 20077:01 amRNSContract Win
10th Aug 20073:39 pmPRNAIM Rule 26
2nd Aug 20077:02 amRNSContract Wins
27th Jul 200712:52 pmPRNDirector/PDMR Shareholding
26th Jul 20077:00 amPRNDirectorate Change and Trading Update
9th Jul 20074:35 pmPRNHolding(s) in Company
3rd Jul 20077:01 amRNSContract win
24th May 20072:50 pmPRNResult of AGM
30th Apr 20073:57 pmPRNTotal Voting Rights
25th Apr 20073:47 pmPRNHolding(s) in Company
24th Apr 200710:02 amPRNHolding(s) in Company
23rd Apr 20073:23 pmPRNHolding(s) in Company
3rd Apr 20075:25 pmPRNIssue of Equity
29th Mar 20077:01 amRNSFinal Results
27th Feb 200710:59 amPRNResult of EGM
2nd Feb 20073:34 pmRNSFurther re Change of Name
18th Jan 20077:01 amRNSChange of Name
12th Jan 20079:41 amPRNHolding(s) in Company
3rd Jan 20077:00 amRNSContracts, Trading Update
22nd Dec 200610:41 amPRNTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.